about
Asymmetric hydrogenation of quinoxalines with diphosphinite ligands: a practical synthesis of enantioenriched, substituted tetrahydroquinoxalines.Cortex Fraxini (Qingpi) Protects Rat Pheochromocytoma Cells against 6-Hydroxydopamine-Induced ApoptosisSynthesis of hexahydrofuro[3,2-c]quinoline, a martinelline type analogue and investigation of its biological activity.Recent advances in research of natural and synthetic bioactive quinolines.Biosorption Performance of Encapsulated Candida krusei for the removal of Copper(II).The puzzling issue of 'vehicle-treated control' when using ethanol as drug carrier for MCF-7 cells.Preparation of 8-hydroxyquinoline derivatives as potential antibiotics against Staphylococcus aureus.The preparation of bi-functional organophosphine oxides as potential antitumor agents.5-(Dimethylamino)-N-(4-ethynylphenyl)-1-naphthalenesulfonamide as a novel bifunctional antitumor agent and two-photon induced bio-imaging probe.Synthesis of 9,9-dialkyl-4,5-diazafluorene derivatives and their structure-activity relationships toward human carcinoma cell lines.Antitumor activity of diethynylfluorene derivatives of gold(I).The preparation of 2,6-disubstituted pyridinyl phosphine oxides as novel anti-cancer agents.A comparative investigation on the biosorption of lead by filamentous fungal biomass.The preparation and in vitro antiproliferative activity of phthalimide based ketones on MDAMB-231 and SKHep-1 human carcinoma cell lines.Air-stable Ir-(P-Phos) complex for highly enantioselective hydrogenation of quinolines and their immobilization in poly(ethylene glycol) dimethyl ether (DMPEG).Antiangiogenic activity of 2-formyl-8-hydroxy-quinolinium chloride.Anti-tumour and pharmacokinetics study of 2-Formyl-8-hydroxy-quinolinium chloride as Galipea longiflora alkaloid analogue.Asymmetric hydrogenation of quinolines with high substrate/catalyst ratio
P50
Q35010519-C289AEDE-3404-460A-99C6-579311FEBBCCQ35989000-885FF56D-7CFD-4C10-9C44-5F5D465027AFQ36650752-8CF42893-1457-48AF-806D-5C4067E33C10Q38523611-B47B9489-5C41-44B0-BFC9-FBD285820158Q38773700-5ED5DFD8-5F9D-4E43-A7CB-EF87A46E88C1Q39005686-D0E7072D-D00D-4AF7-9B8B-B60A797FEF5EQ39057394-ECDB0118-2598-472A-BFD3-06470F313E9DQ39656961-4480F4F4-7209-4C8E-A03F-4A8275F76B49Q39716908-15AD0324-A80E-47DF-AADE-57996FE43473Q39731196-7325DEA5-F6F0-4AB1-A208-385B76F97E51Q39779032-AB5A74E1-70A0-4607-A73A-2C888B198909Q39868348-4A7AD2FC-BC86-4170-8AAF-85D1449E3E9CQ43339037-F86E3B96-E7EE-4E17-8D54-9FB450BCCE22Q46199088-09D2B3E4-63D2-425E-9743-C8ACD402545EQ46366102-CDD5F00A-7A85-4A91-87C4-5FAC5BF72628Q52872008-5FB06742-21C2-4C86-BD62-7CC529711B5AQ53060139-7DF49C3A-FAA5-4916-BFE7-C68CE21476A7Q79693281-3CBE591E-B48B-4C28-A134-5A63356EB827
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2161-2367
@en
name
Kim Hung Lam
@ast
Kim Hung Lam
@en
Kim Hung Lam
@es
Kim Hung Lam
@nl
type
label
Kim Hung Lam
@ast
Kim Hung Lam
@en
Kim Hung Lam
@es
Kim Hung Lam
@nl
prefLabel
Kim Hung Lam
@ast
Kim Hung Lam
@en
Kim Hung Lam
@es
Kim Hung Lam
@nl
P106
P1153
15741398800
57114141700
P31
P496
0000-0003-2161-2367